Status: current, Defined. Date: 31-Oct 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4112091000168119 | Trajentamet 2.5 mg/500 mg (linagliptin 2.5 mg + metformin hydrochloride 500 mg) tablet, 100 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4112101000168112 | Trajentamet 2.5 mg/500 mg tablet, 100 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Trajentamet 2.5 mg/500 mg tablet, 100 | Is a | linagliptin 2.5 mg + metformin hydrochloride 500 mg tablet, 100 | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/500 mg tablet, 100 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Trajentamet 2.5 mg/500 mg tablet, 100 | has TPUU | Trajentamet 2.5 mg/500 mg tablet | true | Inferred relationship | Some | 1 | |
| Trajentamet 2.5 mg/500 mg tablet, 100 | has TP | Trajentamet 2.5 mg/500 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trajentamet 2.5 mg/500 mg tablet, 100, blister pack | Is a | True | Trajentamet 2.5 mg/500 mg tablet, 100 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR